MarketCap
Zimmer Biomet Holdings ZBH
$ 91.57
3.72%
Facebook
X
Telegram
Zimmer Biomet Holdings General and Administrative Expenses | ZBH
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Zimmer Biomet Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.26 B | 2.93 B | 2.84 B | 2.76 B | 2.84 B | 2.71 B | 3.34 B | 3.38 B | 3.37 B | 3.28 B | 2.66 B | - | 1.97 B | 1.91 B | 1.99 B | 1.76 B | 1.73 B | 1.7 B | 1.52 B | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.38 B | 1.52 B | 2.55 B |
Quarterly General and Administrative Expenses Zimmer Biomet Holdings
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q3 | 2009-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 899 M | 850 M | 811 M | 815 M | 759 M | 710 M | 737 M | 736 M | 675 M | 726 M | 716 M | - | 655 M | 695 M | 684 M | - | 684 M | 817 M | 657 M | - | 790 M | 665 M | 829 M | - | 826 M | 839 M | 796 M | - | 788 M | 791 M | 802 M | - | 712 M | 752 M | 758 M | - | 728 M | 732 M | 717 M | - | 692 M | 444 M | 424 M | - | 423 M | 436 M | 444 M | - | 438 M | 458 M | 461 M | - | 430 M | 453 M | 463 M | - | 444 M | 470 M | 458 M | 412 M | 437 M | 447 M | 413 M | 432 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 899 M | 412 M | 639 M |
General and Administrative Expenses of other stocks in the Medical devices industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abbott Laboratories
ABT
|
12.3 B | $ 100.1 | 2.67 % | $ 174 B |  USA |
 |
Aethlon Medical
AEMD
|
2.7 M | $ 6.53 | 1.16 % | $ 4.4 M | USA |
 |
AdaptHealth Corp.
AHCO
|
382 M | $ 5.74 | 2.5 % | $ 776 M | USA |
 |
Align Technology
ALGN
|
1.76 B | $ 140.65 | 0.1 % | $ 10.2 B | USA |
 |
Apyx Medical Corporation
APYX
|
15.8 M | $ 2.6 | 1.96 % | $ 107 M | USA |
 |
Accuray Incorporated
ARAY
|
45.4 M | $ 0.3 | 7.37 % | $ 36.8 M | USA |
 |
Alphatec Holdings
ATEC
|
499 M | $ 10.72 | 6.88 % | $ 1.61 B | USA |
 |
AxoGen
AXGN
|
44.6 M | $ 37.22 | 0.21 % | $ 1.71 B | USA |
 |
Butterfly Network
BFLY
|
39.2 M | $ 9.38 | 4.8 % | $ 2.32 B | USA |
 |
Bio-Rad Laboratories
BIO
|
844 M | $ 379.82 | 2.89 % | $ 10.4 B | USA |
 |
Bruker Corporation
BRKR
|
946 M | $ 63.86 | 0.98 % | $ 9.69 B | USA |
 |
Boston Scientific Corporation
BSX
|
6.89 B | $ 42.4 | 0.31 % | $ 62.8 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
47.1 M | $ 8.77 | 0.34 % | $ 639 M |  Israel |
 |
ClearPoint Neuro
CLPT
|
16.5 M | $ 11.52 | 5.74 % | $ 326 M | USA |
 |
CONMED Corporation
CNMD
|
132 M | $ 47.33 | 2.25 % | $ 1.47 B | USA |
 |
Cytosorbents Corporation
CTSO
|
35.6 M | $ 3.97 | 0.12 % | $ 247 M | USA |
 |
Delcath Systems
DCTH
|
43.5 M | $ 15.87 | 4.89 % | $ 568 M | USA |
 |
Electromed
ELMD
|
42.7 M | $ 28.32 | 0.78 % | $ 234 M | USA |
 |
Establishment Labs Holdings
ESTA
|
165 M | $ 66.47 | 3.76 % | $ 1.97 B |  Costa-rica |
 |
Edwards Lifesciences Corporation
EW
|
2.09 B | $ 87.23 | 2.44 % | $ 51 B | USA |
 |
Globus Medical
GMED
|
1.18 B | $ 76.57 | 1.28 % | $ 10.4 B | USA |
 |
Helius Medical Technologies
HSDT
|
23.1 M | $ 2.65 | 0.76 % | $ 58.4 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
700 M | $ 13.29 | 4.81 % | $ 1.02 B | USA |
 |
Inogen
INGN
|
67.4 M | $ 5.94 | 0.34 % | $ 158 M | USA |
 |
InMode Ltd.
INMD
|
11.7 M | $ 14.13 | 0.28 % | $ 913 M | Israel |
 |
Inspire Medical Systems
INSP
|
625 M | $ 70.75 | 1.11 % | $ 2.08 B | USA |
 |
IRIDEX Corporation
IRIX
|
7.73 M | $ 0.69 | 7.28 % | $ 11.7 M | USA |
 |
IRadimed Corporation
IRMD
|
17.8 M | $ 86.47 | 1.25 % | $ 1.1 B | USA |
 |
Integer Holdings Corporation
ITGR
|
212 M | $ 126.45 | 0.1 % | $ 4.39 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
120 M | $ 22.89 | 3.29 % | $ 537 M | USA |
 |
LivaNova PLC
LIVN
|
549 M | $ 76.43 | 1.81 % | $ 4.17 B |  Britain |
|
LENSAR
LNSR
|
45.2 M | $ 6.67 | 0.59 % | $ 79.8 M | USA |
 |
Pulmonx Corporation
LUNG
|
101 M | $ 1.88 | 2.73 % | $ 76.5 M | USA |
 |
Medtronic PLC
MDT
|
11.8 B | $ 87.97 | 1.88 % | $ 113 B | USA |
 |
MiMedx Group
MDXG
|
56.5 M | $ 4.55 | 0.54 % | $ 672 M | USA |
 |
Myomo
MYO
|
14 M | $ 1.67 | 2.45 % | $ 69.9 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
21.6 M | $ 0.64 | 1.15 % | $ 41.5 M | Israel |
 |
InspireMD
NSPR
|
20.7 M | $ 0.58 | 1.64 % | $ 37.3 M | Israel |
 |
Orthofix Medical
OFIX
|
554 M | $ 9.5 | 4.51 % | $ 376 M |  Curacao |
 |
Outset Medical
OM
|
37.9 M | $ 4.1 | 3.54 % | $ 62.4 K | USA |
 |
PAVmed
PAVM
|
16.2 M | $ 2.66 | 4.36 % | $ 1.78 M | USA |
 |
Penumbra
PEN
|
663 M | $ 317.11 | 0.07 % | $ 12.3 B | USA |
 |
Insulet Corporation
PODD
|
1.16 B | $ 135.62 | 2.98 % | $ 9.54 B | USA |
 |
Profound Medical Corp.
PROF
|
32.1 M | $ 6.03 | 3.25 % | $ 182 M |  Canada |
 |
Quanterix Corporation
QTRX
|
138 M | $ 3.81 | 4.67 % | $ 162 M | USA |
 |
AVITA Medical
RCEL
|
27.4 M | $ 13.25 | 4.17 % | $ 369 M |  Australia |
 |
Sintx Technologies
SINT
|
6.2 M | $ 2.18 | 1.05 % | $ 6.05 M | USA |
 |
Smith & Nephew plc
SNN
|
3.1 B | $ 26.92 | 1.87 % | $ 23.3 B | Britain |
 |
Sensus Healthcare
SRTS
|
7.87 M | $ 2.92 | 0.34 % | $ 47.7 M | USA |
 |
Stryker Corporation
SYK
|
8.65 B | $ 285.22 | 3.54 % | $ 109 B | USA |